In the fourth quarter of 2024, we expect to announce updated data from the VTP-300 program in ongoing clinical trials in chronic hepatitis B at AASLD – The Liver Meeting® 2024 scheduled from November ...

as a result of prior commercial sales of Vaxzevria® by AstraZeneca. We expect that this additional cash, when received, will enable us to fund our research and development plans further into the ...

This helped to offset a decline in AZ's COVID-19 vaccine Vaxzevria, which fell 48% to $451 million. Oncology put in another strong performance, rising 15% to $3.8 billion, with a 7% increase for ...

but showed strong increases in neutralising antibody levels when Gritstone's shot given as a booster after two doses of AstraZeneca's Vaxzevria given as a primary course. It also stimulated broad ...

We report a case of Guillain-Barré syndrome (GBS) occurring soon after the first dose of Vaxzevria (previously known as COVID-19 vaccine AstraZeneca). Thus far, there has been no evidence of an ...

Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and ...

Covid vaccines left Aussie mother-of-two Ellie Sutton in such agony she 'prayed for death' and has considered euthanasia.

At close: 18 October at 4:46 pm GMT-3 ...